Tuberculosis diagnostics: Which target product profiles should be prioritised?

European Respiratory Journal

Volumn 44, Issue 2, 2014, Pages 537-539

  Kik, Sandra V ^a,b   Denkinger, Claudia M ^a,b,c   Casenghi, Martina ^d   Vadnais, Caroline ^a,b   Pai, Madhukar ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT; BIOLOGICAL MARKER;

ARTICLE; ASSAY; BACTERIAL TRANSMISSION; CONSENSUS; DELAYED DIAGNOSIS; DIAGNOSTIC TEST; DISEASE MARKER; DRUG SUSCEPTIBILITY TESTING; HEALTH CARE SYSTEM; HIGH THROUGHPUT SCREENING; HUMAN; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MICROSCOPY; MINIMUM LUNG ALVEOLUS CONCENTRATION; MOLECULAR DIAGNOSIS; MOLECULAR SMEAR REPLACEMENT TEST; MORBIDITY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RAPID TEST; SPUTUM EXAMINATION; TREATMENT RESPONSE; INCIDENCE; INFECTION CONTROL; MICROBIOLOGY; ORGANIZATION; REPRODUCIBILITY; TUBERCULOSIS;

BIOLOGICAL MARKERS; COMMUNICABLE DISEASE CONTROL; CONGRESSES AS TOPIC; DIAGNOSTIC TESTS, ROUTINE; HUMANS; INCIDENCE; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY OF RESULTS; TUBERCULOSIS;

EID: 84905656905     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00027714     Document Type: Article

References (14)

1. World Health Organization. Global Tuberculosis Report 2013. Geneva, WHO, 2013.
2. Weyer K, Mirzayev F, Migliori GB, et al. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur Respir J 2013; 42: 252-271.
3. Denkinger CM, Nicolau I, Ramsay A, et al. Are peripheral microscopy centres ready for next generation molecular tuberculosis diagnostics? Eur Respir J 2013; 42: 544-547.
4. UNITAID. Tuberculosis: Diagnostics Technology and Market Landscape 2013. 2nd Edn. Genenva, WHO, 2013.
5. Graham SM, Ahmed T, Amanullah F, et al. Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis 2012; 205: Suppl. 2, S199-S208.
6. Batz H-G, Cooke GS, Reid SD. Towards lab-free tuberculosis diagnosis. Lausanne, Médecins Sans Frontières, 2011.
7. Denkinger CM, Kik SV, Pai M. Robust, reliable and resilient: designing molecular tuberculosis tests for microscopy centers in developing countries. Expert Rev Mol Diagn 2013; 13: 763-767.
8. Wells WA, Boehme CC, Cobelens FG, et al. Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action. Lancet Infect Dis 2013; 13: 449-458.
9. Pai M, Denkinger CM, Kik SV, et al. Gamma Interferon release assays for detection of Mycobacterium tuberculosis Infection. Clin Microbiol Rev 2014; 27: 3-20.
10. Wallis RS, Kim P, Cole S, et al. Tuberculosis biomarkers discovery: developments, needs, and challenges. Lancet Infect Dis 2013; 13: 362-372.
11. Kik SV, Denkinger CM, Chedore P, et al. Replacing smear microscopy for the diagnosis of tuberculosis: what is the market potential? Eur Respir J 2014; 43: 1793-1796.
12. Pai NP, Vadnais C, Denkinger C, et al. Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries. PLoS Med 2012; 9: e1001306.
13. World Health Organization. An international roadmap for tuberculosis research: towards a world free of tuberculosis. Geneva, WHO, 2011.
14. World Health Organization. Priorities for tuberculosis research. A report of the disease reference group on TB, leprosy and Buruli ulcer. Geneva, WHO, 2013.